CAPSY 500MG TABLET

Capsy 500mg Tablet contains capecitabine, an oral antimetabolite chemotherapy medicine widely used in the treatment of breast cancer, colorectal cancer, and other gastrointestinal cancers. It is converted into its active form within tumor tissues, helping to inhibit cancer cell growth while minimizing systemic exposure. This targeted anticancer therapy is administered strictly under an oncologist’s supervision to ensure safety and effectiveness.

Capsy 500mg Tablet is prescribed to manage cancer progression and reduce tumor size in patients where chemotherapy is indicated. By selectively targeting cancer cells, this anticancer product helps control abnormal cell proliferation while reducing side effects on healthy tissues. Regular monitoring by healthcare professionals ensures optimal dosing, enhanced efficacy, and safe treatment outcomes.

Capsy 500mg Tablet is manufactured in WHO-GMP certified facilities and is suitable for hospital supply, oncology centers, and bulk or export distribution. This trusted product plays a crucial role in modern cancer treatment, offering patients a safe and effective oral chemotherapy option to manage disease progression.

Product Features

• Oral chemotherapy tablet
• Contains Capecitabine 500 mg
• Antimetabolite anticancer drug
• Used in breast and colorectal cancers
• Tumor-activated targeted action
• Convenient oral dosage form
• Manufactured under GMP-compliant standards
• Prescription-required oncology medicine

How It Helps

• Converted into an active form within tumor tissues to inhibit cancer cell growth
• Helps slow disease progression in breast, colorectal, and gastrointestinal cancers
• Targets cancer cells while minimizing effects on healthy tissues
• Supports oral chemotherapy treatment under the oncologist’s supervision